Clinical Trials Logo
  1. Home
  2. Migraine Disorders
  3. NCT05747911
  4. Details
NCT05747911 Clinical Trial

Dietary Advanced Glycation End Products and Migraine

Migraine Disorders Clinical Trial

Official title:
Are Dietary Intake of Advanced Glycation End Products and Migraine Associated? A Case-control Study

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT05747911
Other study ID # Busra Demirer
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 1, 2022
Est. completion date March 1, 2023

Study information
Verified date February 2023
Source Karabuk University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Is dietary intake of advanced glycation different between individuals with and without migraine? Is there a difference between the groups in terms of energy and nutrients? The answers to these questions are sought.

Recruitment information / eligibility
Status Completed
Enrollment 120
Est. completion date March 1, 2023
Est. primary completion date September 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 64 Years
Eligibility Inclusion Criteria: - To be diagnosed with episodic migraine by an experienced neurologist, - For the control group, patients who were not diagnosed with migraine but applied to the headache outpatient clinic - Volunteer Exclusion Criteria: - Being younger than 19 years and older than 64 years of age, having a history of cardiovascular disease, hypertension, diabetes, cancer, liver and kidney disease or other neurological disorder (epilepsy, multiple sclerosis, stroke, traumatic brain injury, etc.), secondary headache, antilipidemic and glucose taking intolerance medications or vitamin-mineral supplements, following a special diet, and consuming less than 800 kcal or more than 4000 kcal per day

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Turkey Karabuk University Karabük

Sponsors (1)
Lead Sponsor Collaborator
Karabuk University

Country where clinical trial is conducted

Turkey, 

Outcome
Type Measure Description Time frame Safety issue
Primary Difference in dietary advanced glycation end products intake between groups Is there a difference between the dietary intake of advanced glycation end products in individuals with migraine and healthy individuals? These values will be obtained from the food consumption records of the individuals. Intake of advanced glycation end product will be evaluated as ....kU/day.
Is there a difference between the energy and nutrient intake of individuals with migraine and healthy individuals?		 2 months
See also
  Status Clinical Trial Phase
Completed NCT01432379 - BOTOX® Prophylaxis in Patients With Chronic Migraine
Completed NCT04084314 - Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study Phase 4
Recruiting NCT05048914 - Migraine Abortive Treatment
Completed NCT03662295 - Stroke-like Migraine Attacks After Radiation Treatment (SMART) Syndrome Language Intervention
Completed NCT02766517 - Biomarker Study in Participants With Migraine Early Phase 1
Completed NCT00963937 - Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents Phase 3
Not yet recruiting NCT03632928 - Day to Day Variation of Pressure Pain Threshold and Muscle Hardness
Completed NCT02559895 - A Multicenter Assessment of ALD403 in Frequent Episodic Migraine Phase 3
Completed NCT01435941 - Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine N/A
Completed NCT00743015 - Relative Bioavailability of a Single Dose of BI 44370 Tablet During and Between Migraine Attacks Phase 1
Completed NCT01376141 - Drug Use Investigation for IMIGRAN Tablet N/A
Completed NCT02183688 - Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients Phase 3
Completed NCT06061588 - "Potential Effects of Virtual Reality Technology on the Treatment of Migraine-Type Headaches" N/A
Completed NCT03588364 - The Role of Osteopathic Manipulation in the the Management of Post-traumatic Migraine N/A
Completed NCT04091321 - Association Between Chronic Headache and Back Pain With Childbirth
Completed NCT00385008 - TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine Phase 3
Active, not recruiting NCT05888298 - Proximal and Distal Approach GON RFT in Migraine N/A
Completed NCT03435185 - Greater Occipital and Supraorbital Nerve Blockade in Migraine Patients N/A
Recruiting NCT06459635 - Migraine Attack Pain Phase Prediction Study
Completed NCT02565186 - An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine Phase 3